<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">METHOXAMINE HYDROCHLORIDE <img border="0" src="../images/pr.gif"/></span><br/>(meth-ox'a meen)<br/><span class="topboxtradename">Vasoxyl<br/></span><b>Classifications:</b> <span class="classification">autonomic nervous system agent</span>; <span class="classification">alpha-adrenergic agonist (sympathomimetic)</span><br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>20 mg/mL ampules</p>
<h1><a name="action">Actions</a></h1>
<p>Direct-acting sympathomimetic amine pharmacologically related to phenylephrine. Acts almost exclusively on alpha-adrenergic
         receptors. Pressor action is due primarily to direct peripheral vasoconstriction, which in turn causes rise in arterial BP.
         Has no direct effect on heart. Markedly reduces renal blood flow. Tends to slow ventricular rate by vagal stimulation in response
         to elevated BP.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Terminates episodes of paroxysmal supraventricular tachycardia. Large doses may produce bradycardia. CNS-stimulating action.
         True tachyphylaxis not reported.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>To support, restore, or maintain BP during anesthesia and to terminate some episodes of paroxysmal supraventricular tachycardia.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Severe coronary or cardiovascular disease; hypovolemia, in combination with local anesthetics for tissue infiltration; within
         2 wk of MAO inhibitors; pregnancy (category C).
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>History of hypertension or hyperthyroidism; following use of ergot alkaloids; lactation. Safety and effectiveness in children
         are not established.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Hypotension during Anesthesia</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IM</span> 520 mg <span class="rdroute">IV</span> 35 mg<br/><span class="rdage">Child:</span> <span class="rdroute">IM</span> 0.25 mg/kg <span class="rdroute">IV</span> 0.08 mg/kg<br/><br/><span class="indicationtitle">Paroxysmal Supraventricular Tachycardia</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IM</span> 1020 mg <span class="rdroute">IV</span> 515 mg over 35 min<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Intramuscular</span><br/><ul>
<li>Give supplemental IM, as needed, after emergency IV infusion.</li>
</ul>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><p><span class="routemethod">PREPARE:</span> <span class="methodtype">Direct:</span> Give undiluted.  <span class="methodtype">IV Infusion:</span> May be diluted in 250 mL D5W.  
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype">Direct:</span> Give at a rate of 5 mg/min if systolic BP is less than 60 mm Hg.  <span class="methodtype">IV Infusion:</span> Give at rate needed to maintain BP.  
               </p>
<ul>
<li>Be alert for extravasation. Antidote: Infiltrate area as soon as possible with 1015 mL NS saline solution containing
                     510 mg phentolamine.
                  </li>
<li>Protect drug from light.</li>
</ul>
</td>
</tr>
</table>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> Body as a Whole:</span> Paresthesias, feeling of coldness (particularly with high dosage), restlessness, nervousness. <span class="typehead">CV:</span> High BP, bradycardia. <span class="typehead">GI:</span> Projectile vomiting. <span class="typehead">CNS:</span> Severe headache, pilomotor erection (gooseflesh). <span class="typehead">Urogenital:</span> Urinary urgency. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Phentolamine</b> and <span class="classification">phenothiazines</span> block vasopressor response. <span class="classification">beta blockers</span> may increase amount of methoxamine available to receptor sites. <b>Atropine</b> blocks reflex bradycardia and enhances vasopressor effects. <span class="classification">mao inhibitors</span>, <b>vasopressin,</b> and <span class="classification">ergot alkaloids</span> may cause hypertensive crisis. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Onset:</span> Immediately after IV. <span class="typehead">Peak:</span> 0.52 min IV; 1520 min IM. <span class="typehead">Duration:</span> 515 min IV; 6090 min IM. <span class="typehead">Metabolism:</span> Unknown. <span class="typehead">Elimination:</span> Unknown. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Supervise patients closely.</li>
<li>Monitor vital signs continuously. Report any increase in BP above level prescribed by physician; report slowing of HR.</li>
<li>Be alert for sudden changes in BP and pulse after drug has been discontinued.</li>
<li>Monitor I&amp;O. Urinary frequency with retention is a possibility. Report oliguria or change in I&amp;O ratio.</li>
<li>Methoxamine injection contains a bisulfite, an allergen for some patients.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report headache to physician; it may be severe. This adverse effect may require analgesia for relief.</li>
<li>Report nausea to physician; it may be accompanied by projectile vomiting.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>